Aspiriant LLC’s Schwab US REIT ETF SCHH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-43,676
Closed -$1M 208
2019
Q4
$1M Sell
43,676
-2,136
-5% -$49.8K 0.09% 96
2019
Q3
$1.08M Hold
45,812
0.1% 102
2019
Q2
$1.02M Hold
45,812
0.08% 106
2019
Q1
$1.02M Sell
45,812
-5,572
-11% -$118K 0.08% 111
2018
Q4
$990K Buy
51,384
+5,042
+11% +$103K 0.08% 105
2018
Q3
$967K Sell
46,342
-1,376
-3% -$29.1K 0.08% 109
2018
Q2
$997K Sell
47,718
-2,524
-5% -$49.9K 0.09% 106
2018
Q1
$961K Buy
+50,242
New +$968K 0.08% 108

Other funds holding SCHH

Aspiriant LLC's SCHH Position: Q1 2020 in Review

Aspiriant LLC sold out of Schwab US REIT ETF (SCHH) in Q1 2020, closing a stake of 43,676 shares — an estimated $1M sold.

Aspiriant LLC first reported a position in SCHH in Q1 2018 and held it in 8 quarters. The position peaked at $1.08M in Q3 2019. 400 funds tracked by Wall St. Rank hold SCHH as of Q1 2020.

  • Aspiriant LLC reported no remaining Schwab US REIT ETF position as of Q1 2020 after selling out during the quarter.
  • Aspiriant LLC sold 43,676 Schwab US REIT ETF shares in Q1 2020, an estimated $1M.
  • Aspiriant LLC first reported a position in Schwab US REIT ETF in Q1 2018 and held it in 8 quarters.
  • Aspiriant LLC's Schwab US REIT ETF position peaked at $1.08M in Q3 2019.
  • 400 funds tracked by Wall St. Rank held Schwab US REIT ETF as of Q1 2020.

Based on Aspiriant LLC's 13F filing for Q1 2020, filed 5 May 2020.